Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
clinical trials
drugs
5
×
fda
indiana blog main
indiana top stories
5
×
life sciences
national blog main
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
national
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
cancer
eli lilly
teva pharmaceutical
amgen
calcitonin gene-related peptide
deals
investing
medical device
merck
migraine
What
fda
5
×
drug
approved
new
approval
bio
class
companies
drugs
migraine
roundup
won
ahead
announced
arguments
asco
big
branded
cancer
choices
commercialized
commissioner
competitors
consumers
costly
counterweight
decades
decision
deeper
developed
digital
disease
dna
elevatebio
eli
epidemic
fatty
fingerprint
frenzied
generic
Language
Current search:
drugs
×
" indiana top stories "
×
fda
×
@xconomy.com
5 years ago
Bio Roundup: Generic Drugs Graft, ASCO Ahead, ElevateBio Rises & More
@xconomy.com
5 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Genetic Medicine: FDA OKs 2nd Cancer Drug that Targets DNA, not Tissues
@xconomy.com
5 years ago
Eli Lilly Migraine Drug Approved, the Third in New Class of Medicines